Agilysys is trading at $110.11, up +4.16%, with no clear company-specific news found to explain the October 13 move. - Oppenheimer reiterated its Outperform rating and $118 price target in coverage published October 12, but the report does not establish that it drove the gain. - The broader market was slightly lower, so the provided context does not indicate a broad-market explanation. - Trading volume information was unavailable.